Clinical Trial Update: Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)

View source ↗

Summary

This clinical trial update describes a conditioning regimen with cyclophosphamide, fludarabine, and antithymocyte globulin for myelodysplastic syndromes and not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Myelodysplastic Syndrome | Status: UNKNOWN